Align Technology, Inc. reported fourth quarter 2024 total revenues of $995.2 million on February 5, 2025, an increase of 4.0% year-over-year and 1.8% sequentially, aligning with its Q4 outlook. For the full fiscal year 2024, total revenues reached $4.0 billion, up 3.5% year-over-year.
Q4 Clear Aligner volumes grew 6.1% year-over-year to 628.7 thousand shipments, driven by strength in EMEA, APAC, and LATAM regions, and stability in North America. The Systems and Services segment continued its strong performance, with revenues increasing 14.9% year-over-year to $200.9 million. Non-GAAP diluted EPS for Q4 was $2.44, surpassing analyst estimates.
Despite these positive aspects, Align provided a downbeat Q1 2025 revenue outlook of $965 million to $985 million, below consensus estimates, and projected Clear Aligner ASPs to be down year-over-year for fiscal 2025 due to product mix shifts. The company also announced a $30.0 million equity investment in Smile Doctors and completed $353 million in stock repurchases during 2024, ending the year with no debt and $1,043.9 million in cash.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.